Sotera Health (NASDAQ:SHC) Rating Increased to Strong-Buy at The Goldman Sachs Group

Posted by Geri Gentry on Jun 6th, 2026

Sotera Health (NASDAQ:SHC – Get Free Report) was upgraded by equities research analysts at The Goldman Sachs Group to a “strong-buy” rating in a report released on Friday,Zacks.com reports.

Several other equities research analysts have also recently issued reports on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Weiss Ratings cut shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Citigroup lifted their target price on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th. Finally, Barclays lowered their price target on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $20.29.

Read Our Latest Report on Sotera Health

Sotera Health Price Performance

NASDAQ:SHC opened at $15.62 on Friday. The company has a 50 day moving average price of $15.37 and a 200-day moving average price of $16.36. Sotera Health has a 1-year low of $10.80 and a 1-year high of $19.85. The firm has a market cap of $4.45 billion, a price-to-earnings ratio of 38.10 and a beta of 1.79. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54.

Sotera Health (NASDAQ:SHC – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The firm had revenue of $280.05 million for the quarter, compared to analysts’ expectations of $270.78 million. During the same quarter last year, the company earned $0.14 EPS. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities research analysts forecast that Sotera Health will post 0.86 EPS for the current year.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 15.36% of the stock is owned by company insiders.

Institutional Trading of Sotera Health

Large investors have recently made changes to their positions in the company. Bank of America Corp DE boosted its holdings in Sotera Health by 332.7% in the first quarter. Bank of America Corp DE now owns 1,289,649 shares of the company’s stock valued at $18,494,000 after purchasing an additional 991,620 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in Sotera Health by 35.3% in the first quarter. Janus Henderson Group PLC now owns 9,162,191 shares of the company’s stock valued at $131,413,000 after purchasing an additional 2,390,132 shares in the last quarter. Bull Harbor Capital LLC acquired a new position in Sotera Health in the first quarter valued at approximately $158,000. Irenic Capital Management LP boosted its holdings in Sotera Health by 14.8% in the first quarter. Irenic Capital Management LP now owns 4,359,348 shares of the company’s stock valued at $62,513,000 after purchasing an additional 561,322 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in Sotera Health by 52.1% in the first quarter. EverSource Wealth Advisors LLC now owns 11,518 shares of the company’s stock valued at $165,000 after purchasing an additional 3,946 shares in the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

About Sotera Health

(Get Free Report)

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.